Eighty United States students in Mexico received either loperamide (an initial dose of 4 mg, followed by 2 mg after passage of each unformed stool, up to 8 mg/d; 40 patients) or loperamide (at the same dosage schedule) plus an oral rehydration therapy (ORT) preparation (500 mL initially, followed by 250 mL after each subsequently passed unformed stool, up to 1,000 mL per 24 hours; 40 patients). The ORT preparation was a modification of the World Health Organization -recommended solution, adjusted to a sodium concentration of 60 mEq/L. All treatments were given for 48 hours. The study demonstrated equivalent clinical responses with regard to diminishment of diarrhea or subjective findings such as abdominal pain/cramps, headache, dry mouth, dizziness, or thirst. Stool number (by form) and specific gravity of urine postenrollment were similar in the groups. Administration of loperamide plus ORT for the management of traveler's diarrhea, in cases in which subjects were encouraged to drink ad libitum, offered no benefit over administration of loperamide alone. ing the daily visits.
8 mg per 24 hours) or they were given loperamide (with the as 21% in cases of treated cholera [5] . It is not known whether same dosage schedule) plus ORT solution (500 mL initially, ORT either decreases associated symptomatology in nondehydratwith 250 mL after each subsequent unformed bowel movement, ing diarrheal disease or adds to fluid losses. The present study was up to 1,000 mL per 24 hours). The initial dose of medication designed to determine whether ORT might worsen diarrhea or was taken in the presence of the study coordinator; thereafter, diminish associated symptoms in cases of traveler's diarrhea doses were self-administered and compliance was checked durtreated with loperamide.
ing the daily visits.
The ORT preparation was a modification of the solution Methods recommended by the World Health Organization (concentrations in water: glucose, 20.0 g/L; sodium chloride, 3.5 g/L; This was a single-center, investigator-blinded, parallel group sodium bicarbonate, 2.5 g/L; and potassium chloride, 1.5 g/L), study conducted in 1990, in Guadalajara, Mexico, among prepared by the study sponsor to have a sodium concentration United States students during a short-term stay (3 -6 weeks).
of 60 mEq/L rather than 90 mEq/L. Sealed plastic bottles containing 250 mL of sterile water were provided for reconstituting each packet of ORT powder. The study treatment period was 48 hours. in the daily diary. After the first sample was obtained, stools were not collected.
The following subjective diarrhea-related symptoms were score, and they are advantageous in clinical research where evaluated, all on a linear analog scale: abdominal pain, headtime may be limited [7] . Subjective symptoms were evaluated ache, dry mouth, nausea, vomiting, weakness/tiredness, dizziby this method. Efficacy data, as measured by the 10 items on ness, achiness/cramping, and thirst. Objective measurements the VAS and the mean for those 10 items, were explored for were also evaluated; these included number and consistency possible treatment effects with use of averages obtained for of stools passed (formed, retains its shape; soft, takes the shape each time interval separated and then with use of a weighted of the container; or watery, can be poured) and presence of average of the time periods for each day. Two-sample t tests, gross blood or mucus. Volume of stool and urine was not as implemented in the TTEST procedure of SAS (SAS softmeasured. Side effect information was elicited from each paware; SAS Institute, Cary, NC) were conducted on the actual tient and recorded as to absence or presence, type, severity, average values of the differences between baseline and meaand outcome. Subjects were permitted to select their own diet. surement reported at several time periods after treatment. ComThey were required to estimate their fluid intake (number of parisons of the treatment groups with respect to the stool form 8-oz cups) each day.
and number passed and specific gravity of urine were conducted Since this study was investigator-blinded, medication was with use of two-sample t tests, as implemented in the TTEST dispensed to each patient by the study coordinator. Each patient procedure of SAS software. was advised not to discuss the specific product information with the investigator during study visits. The study was approved by The University of Texas Health Science Center at Houston's Results Committee for the Protection of Human Subjects. All persons included in the study signed a consent form.
Eighty-three subjects were enrolled in the study and 80 completed it. Two subjects were never formally enrolled and one Sample size. The sample size selected was standard for treatment studies of antidiarrheal and antimicrobial agents in dropped out before the final evaluation and was lost to followup. Forty were randomized into the loperamide group and 40 cases of diarrhea [6] . In a placebo-controlled study in which a 30% difference in outcome with a placebo cure rate of 50% is into the loperamide plus ORT group. There was no significant difference between treatment groups with respect to demoassumed, 40 subjects per group would need to be evaluable to demonstrate a significant difference between groups, at graphics or the severity of subjective or objective symptoms or signs prior to treatment. Fifty-two subjects were men and P Å .05 with a statistical power of 0.80 (two-sided test).
Statistical analysis. Statistical methods included a visual 28 were nonlactating females aged 18 -47 years. The treatment groups were compared with respect to age, weight, height, analog scale (VAS) model. A VAS usually consists of a line 10 cm long with verbal anchors at either end, as in this VAS systolic and diastolic blood pressure, oral temperature, pulse, respiration, and number of hours between onset of diarrhea for nausea:
None
Severe (nausea (no nausea) as bad as it could possibly be)
The patient was asked to place a mark through the line at the and initiation of medication. The treatment groups were also comparable with respect to the severity of illness prior to therpoint that best described the severity of the symptom experienced at that particular moment. Interval VAS data were obapy. Relevant demographic characteristics of the 80 patients evaluated are shown in table 1. tained by measuring from the left end of the scale to the mark made by the patient. VAS analyses are easy to administer and Data concerning subjective symptoms were compared for / 9c68$$ju15 05-11-99 12:31:24 cidal UC: CID the 4-hour period prior to therapy; the first, second, and third watery and soft), and formed stools passed showed no statistically significant differences by time periods after enrollment 4-hour intervals on day 1 of treatment; and the following 12-hour intervals (table 2) . Means of symptom-intensity values in in the study (table 3) . The number of watery stools passed for 4 hours pretreatment was significantly greater in the loperamide the two treatment groups, determined from the corresponding VASs, were compared for differences. In addition, weighted group than in the loperamide plus ORT group. For the time period of 0 -24 hours, subjects randomized to receive loperaaverages of groups were compared by day of study (data not shown). There was a significant difference between treatments mide took an average of 3.3 doses of loperamide, compared with 3.1 (NS) in the loperamide plus ORT group. The average in the mean values for achiness/cramping for the first 4 hours of day 1 of treatment (loperamide plus ORT, 0.30; loperamide, values for doses of loperamide during the time period of 24 -48 hours were 0.63 in the former group and 0.64 in the latter 1.19; P Å .011) (table 2). The 10 subjective measures of symptomatic relief and the mean of these items were also examined group. The average fluid intake also did not vary significantly: at with use of repeated measures analyses of variance. These analyses showed significant differences between treatments 0 -24 hours, 9.6 8-oz cups (including treatment volume) in the loperamide group vs. 8.2 cups (NS) in the loperamide plus only at hour 4 for chills (loperamide Å 1.44; loperamide plus ORT Å 0.66) (data not shown) and at hour 36 for thirst 8.39 cups vs. 7 .12 cups, respectively. There were also no statistically significant differmide Å 1.03; loperamide plus ORT Å 2.27). Only two comparisons among the 66 made showed significant differences. These ences between treatment groups with regard to adverse reactions. Four subjects in the loperamide group reported minor differences appeared to be a result of chance rather than meaningful differences.
adverse experiences and six subjects in the loperamide plus ORT group had a possible adverse experience. None were felt Comparisons between treatment groups with respect to mean number of watery stools, soft stools, unformed stools (sum of to be clinically important. Table 3 . Comparison of mean numbers of stools (by form) and values for specific gravity of urine in the two treatment groups, during different time periods before (04 hours) and during therapy. Patients started their treatment regimen at Ç24 hours after ORT is an uncomplicated, low-cost, and easily obtainable onset of symptoms because of the study design. If therapy had antidote to the dehydration that accompanies diarrhea. ORT has been initiated sooner after onset of symptoms, different effects contributed substantially to the saving of lives in developing of ORT could have been found. countries [8] . It has also been recommended for fluid replaceOn the basis of the findings of this study, we feel that travelment in persons with traveler's diarrhea [8, 9] . We decided to ers should be educated about the utility of taking in fluids and carry out the study to corroborate the utility of ORT in the salt from local beverage and food sources during their bout of treatment of traveler's diarrhea and associated symptoms, since diarrhea. Travelers to remote, unpopulated, high-risk regions there had been no prior studies addressing the topic.
where fluids and salt may be less readily available, on the The present study revealed that the use of an ORT solution other hand, probably should be armed with packets of an ORT with a sodium concentration of 60 mEq/L, compared with fluids preparation before departure. taken ad libitum, was of little value as additional treatment for travelers taking loperamide for relief of diarrhea. The few
